Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China
· Delayed Price · Currency is CNY 18.60
-0.87 (-4.47%)
Jun 26, 2025, 2:52 PM CST
SHA:600521 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 9,364 | 9,495 | 8,249 | 8,183 | 6,603 | 6,456 | Upgrade
|
| Other Revenue | 52.87 | 52.87 | 59.54 | 82.56 | 40.95 | 29.5 | Upgrade
|
| Revenue | 9,417 | 9,547 | 8,309 | 8,266 | 6,644 | 6,485 | Upgrade
|
| Revenue Growth (YoY) | 7.65% | 14.91% | 0.52% | 24.42% | 2.44% | 20.36% | Upgrade
|
| Cost of Revenue | 3,566 | 3,738 | 3,376 | 3,180 | 2,671 | 2,385 | Upgrade
|
| Gross Profit | 5,851 | 5,809 | 4,933 | 5,086 | 3,973 | 4,100 | Upgrade
|
| Selling, General & Admin | 3,184 | 3,143 | 2,592 | 2,534 | 2,448 | 2,080 | Upgrade
|
| Research & Development | 1,012 | 986.69 | 982.99 | 925.53 | 942.26 | 565.7 | Upgrade
|
| Other Operating Expenses | 21.45 | 18.41 | 5.69 | 3.63 | 65.21 | 50.13 | Upgrade
|
| Operating Expenses | 4,268 | 4,185 | 3,572 | 3,508 | 3,470 | 2,725 | Upgrade
|
| Operating Income | 1,583 | 1,625 | 1,360 | 1,578 | 502.48 | 1,375 | Upgrade
|
| Interest Expense | -214.88 | -219.8 | -231.69 | -220.02 | -166.34 | -135.33 | Upgrade
|
| Interest & Investment Income | 48.36 | 53.22 | 39.48 | 25.83 | 180.61 | 19.57 | Upgrade
|
| Currency Exchange Gain (Loss) | 76.9 | 76.9 | 60.1 | 208.94 | -50.99 | -145.37 | Upgrade
|
| Other Non Operating Income (Expenses) | -13.65 | -5.8 | -5.14 | -3.91 | -4.32 | -3.86 | Upgrade
|
| EBT Excluding Unusual Items | 1,480 | 1,529 | 1,223 | 1,589 | 461.44 | 1,110 | Upgrade
|
| Impairment of Goodwill | - | - | -6.46 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -26.99 | -98.21 | -162.9 | -70 | 299.81 | 26.09 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.06 | 2.33 | -0.29 | -16.1 | -9.59 | 19.15 | Upgrade
|
| Asset Writedown | -52.23 | -30.13 | -32.95 | -2 | -0.16 | -13.58 | Upgrade
|
| Other Unusual Items | 64.25 | 60.55 | 79.92 | 8.23 | 35.42 | 73.68 | Upgrade
|
| Pretax Income | 1,467 | 1,464 | 1,100 | 1,509 | 786.93 | 1,215 | Upgrade
|
| Income Tax Expense | 337.22 | 356.15 | 283.07 | 332.89 | 306.28 | 220.76 | Upgrade
|
| Earnings From Continuing Operations | 1,130 | 1,107 | 817.25 | 1,176 | 480.64 | 994.6 | Upgrade
|
| Minority Interest in Earnings | 15.98 | 11.52 | 13.22 | -8.25 | 6.89 | -64.78 | Upgrade
|
| Net Income | 1,146 | 1,119 | 830.47 | 1,168 | 487.54 | 929.82 | Upgrade
|
| Net Income to Common | 1,146 | 1,119 | 830.47 | 1,168 | 487.54 | 929.82 | Upgrade
|
| Net Income Growth | 23.39% | 34.74% | -28.88% | 139.52% | -47.57% | 63.24% | Upgrade
|
| Shares Outstanding (Basic) | 1,447 | 1,449 | 1,457 | 1,442 | 1,434 | 1,453 | Upgrade
|
| Shares Outstanding (Diluted) | 1,447 | 1,449 | 1,457 | 1,460 | 1,434 | 1,453 | Upgrade
|
| Shares Change (YoY) | -0.42% | -0.52% | -0.19% | 1.80% | -1.30% | 4.58% | Upgrade
|
| EPS (Basic) | 0.79 | 0.77 | 0.57 | 0.81 | 0.34 | 0.64 | Upgrade
|
| EPS (Diluted) | 0.79 | 0.77 | 0.57 | 0.80 | 0.34 | 0.64 | Upgrade
|
| EPS Growth | 23.58% | 35.09% | -28.75% | 135.29% | -46.88% | 56.10% | Upgrade
|
| Free Cash Flow | -246.1 | 319.33 | 624.63 | -1,074 | -1,496 | 278.97 | Upgrade
|
| Free Cash Flow Per Share | -0.17 | 0.22 | 0.43 | -0.73 | -1.04 | 0.19 | Upgrade
|
| Dividend Per Share | 0.250 | 0.250 | 0.200 | 0.240 | 0.100 | 0.200 | Upgrade
|
| Dividend Growth | 25.00% | 25.00% | -16.67% | 140.00% | -50.00% | 10.01% | Upgrade
|
| Gross Margin | 62.13% | 60.85% | 59.37% | 61.53% | 59.80% | 63.23% | Upgrade
|
| Operating Margin | 16.81% | 17.02% | 16.37% | 19.09% | 7.56% | 21.20% | Upgrade
|
| Profit Margin | 12.16% | 11.72% | 9.99% | 14.13% | 7.34% | 14.34% | Upgrade
|
| Free Cash Flow Margin | -2.61% | 3.35% | 7.52% | -12.99% | -22.52% | 4.30% | Upgrade
|
| EBITDA | 2,495 | 2,510 | 2,141 | 2,230 | 1,050 | 1,846 | Upgrade
|
| EBITDA Margin | 26.49% | 26.29% | 25.76% | 26.98% | 15.81% | 28.46% | Upgrade
|
| D&A For EBITDA | 912.04 | 885.71 | 780.37 | 652.55 | 547.8 | 470.83 | Upgrade
|
| EBIT | 1,583 | 1,625 | 1,360 | 1,578 | 502.48 | 1,375 | Upgrade
|
| EBIT Margin | 16.81% | 17.02% | 16.37% | 19.09% | 7.56% | 21.20% | Upgrade
|
| Effective Tax Rate | 22.99% | 24.33% | 25.73% | 22.06% | 38.92% | 18.16% | Upgrade
|
| Revenue as Reported | 9,417 | 9,547 | 8,309 | 8,266 | 6,644 | 6,485 | Upgrade
|
| Advertising Expenses | - | 1,417 | 1,036 | 1,034 | 999.39 | 783.51 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.